Rumensin Premix (Canada)

This page contains information on Rumensin Premix for veterinary use.
The information provided typically includes the following:
  • Rumensin Premix Indications
  • Warnings and cautions for Rumensin Premix
  • Direction and dosage information for Rumensin Premix

Rumensin Premix

This treatment applies to the following species:
Manufacturer: Elanco

AF 1406

Monensin with Microtracer®

DIN 02231173

PREMIX FOR USE IN CATTLE FEEDS

Rumensin Premix Indications

1. For improved feed efficiency in beef cattle (steers and heifers) fed in confinement for slaughter.

2. As an aid in the prevention of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle. Note to user: Coccidiosis occurs sporadically in first lactation dairy heifers, but is not considered a significant disease in mature dairy cows.

3. For increased rate of weight gain in growing cattle on pasture (slaughter, stocker and feeder cattle, and beef and dairy replacement heifers) of greater than 180 kg (400 lb) body weight.

4. For reduction of milk fat percentage in dairy cows.

5. For minimizing loss of body condition during lactation in dairy cows.

6. For improving feed efficiency of milk protein production in dairy cows.

IMPORTANT: Must be thoroughly mixed in feeds before use.

ACTIVE DRUG INGREDIENT:

Monensin (as monensin sodium)

200.0 g per kilogram

MIXING DIRECTIONS: (Complete diet)

For claims 1, 2, 3, 4, 5 and 6: Rumensin Premix can be mixed in dry supplements prior to final mixing.

For claims 1 and 2: Rumensin Premix can be used in the following thixotrope liquid supplement: Promolas Liquid Supplement Suspension, Westway Feed Products.

Claim 1: Mix not less than 165 g and not more than 240 g Rumensin Premix per tonne (1,000 kg) (to provide not less than 33 g and not more than 48 g monensin activity) to market weight.

Claim 2: Mix 110 g Rumensin Premix per tonne (1,000 kg) (to provide 22 g monensin activity).

Claim 4 and 6: Mix not less than 80 g and not more than 120 g Rumensin Premix per tonne (1,000 kg) (to provide not less than 16 g and not more than 24 g monensin activity).

Claim 5: Mix not less than 40 g and not more than 120 g Rumensin Premix per tonne (1,000 kg) (to provide not less than 8 g and not more than 24 g monensin activity).

Medicated supplement/premix fed as a % of total diet dry matter:

Including the medicated supplement/premix as a % of total dry matter is ideal. If the supplement/premix is to be fed as a % of total diet dry matter, to meet the approved drug level in the complete feed, the amount of monensin sodium required per kg of supplement/premix dry matter is calculated by dividing the approved drug level by the desired % inclusion of supplement/premix into the diet on a 100% dry matter basis:

mg monensin/kg supplement/premix =

Approved drug level (mg/kg/total diet)

____________________________________

% supplement/premix of total diet dry matter

x 100

Medicated supplement/premix fed as a fixed amount per head per day:

If the medicated supplement/premix is to be fed as a fixed amount per head in the total diet, the approved levels of monensin sodium must be converted to mg per head per day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) x dry matter intake as a % of body weight (%) x approved drug level (mg/kg total diet).

This calculation has been made for a wide range of body weights, using six different dry matter intake levels and is presented in “Daily Intake of Monensin Activity” tables found in the Rumensin Technical Reference Guide Addendum. These calculations represent the correct levels of monensin sodium required per head per day for a given body weight.

NOTE:

1. All rations should be corrected to a 100% DRY MATTER BASIS.

2. For intermediate blending of secondary premixes and/or supplements, and the use of dry or thixotrope liquid supplements, to provide the required dosages, see the Rumensin Technical Reference Guide Addendum.

3. All secondary premixes and supplements must be thoroughly mixed in the total daily diet or in complete feed (grain portion of the ration) before use. Do not feed undiluted.

4. Consult your veterinarian and/or nutritionist for additional information regarding the use of monensin in lactating dairy cattle.

MIXING DIRECTIONS: (Medicated Supplement)

Claim 3: The medicated supplement must be prepared so that when it is hand fed as directed, at a minimum of 0.5 kg/head/day, it provides 200 mg of monensin activity per head per day. For example, if the medicated supplement is to be hand fed at 0.5 kg per head per day, it must have 2 kg of Rumensin Premix added to it per 1000 kg of supplement. The medicated supplement must be hand fed from the beginning to the end of the pasture season.

NOTE: Thixotrope liquid medicated supplements should not be used for hand feeding of cattle on pasture.

FEEDING DIRECTIONS: (Complete Diet: which includes complete feed plus roughage)

Claim 1: Feed continuously at a rate of not less than 33 g and not more than 48 g monensin activity per tonne (1,000 kg) until animals reach market weight.

Claim 2: Feed continuously at a rate of 22 g monensin activity per tonne (1,000 kg) during periods of exposure to coccidiosis or when coccidiosis is likely to be a hazard.

Claim 4: Feed continuously at a rate of not less than 16 g and not more than 24 g monensin activity per tonne (1,000 kg).

Claim 5: Feed continuously at a rate of not less than 8 g and not more than 24 g monensin activity per tonne (1,000 kg).

Claim 6: Feed continuously at a rate of not less than 16 g and not more than 24 g monensin activity per tonne (1,000 kg).

FEEDING DIRECTIONS: (Medicated Supplement)

Claim 3: Hand feed at 200 mg of monensin activity per head per day in medicated supplement.

NOTE:

Claim 1: The data used to support a claim for feed efficiency for a dose range of 33 to 48 ppm was derived from a meta-analysis, including 11 studies and more than 11,000 animals. This analysis demonstrated an additional improvement in feed efficiency of 0.05 units on a “deads out” basis in cattle fed 48 ppm when compared with those fed 33 ppm. In some herds, no additional improvement in feed efficiency was shown from feeding Rumensin Premix at levels greater than 33 ppm. Decisions on the appropriate dose of Rumensin Premix should be made in consultation with your veterinarian.

Claim 4: The expected efficacy of this product for reduction of milk fat percentage may be affected by dietary factors. Reduced efficacy may be expected with diets higher in fibre or lower in unsaturated oils.

Warnings

1. For claims 1, 2, and 3: Do not supplement monensin from other sources (eg. other feedstuffs containing monensin or the Rumensin Controlled Release Capsule).

2. For claims 4, 5, and 6: Do not supplement Rumensin Premix above 16 ppm to dairy cows in herds administered the Rumensin Controlled Release Capsule.

3. No pre-slaughter withdrawal period or milk withholding time is required when this drug product is used according to the label directions.

4. When mixing and handling Rumensin, use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling.

5. Keep out of reach of children.

CAUTIONS:

1. Do not exceed recommended levels as reduced average daily gains may result.

2. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.

3. Do not use Rumensin medicated feed for the treatment of outbreaks of coccidiosis.

4. May be used in feeds containing the pellet-binding agents, Bentonite (2%), Attapulgite (2%), Kaolin (2.5%), Lignin Sulfonate (4%), Carboxymethylcellulose (0.1%) or Agri- Colloid.

5. NOT TO BE USED AFTER EXPIRATION DATE. Do not use thixotropic supplement after eight weeks storage. (Westway Feed Products)

6. The 24 g/tonne monensin treatment in primiparous cows may result in increased incidence of udder edema and increased number of inseminations per full term conception.

7. The continuous use of monensin in dairy cows may be associated with increased rates of twinning and stillbirths, and heavier birth weights for heifer calves.

PREMIX FOR USE IN BROILER CHICKEN AND GROWING TURKEY FEEDS

Rumensin Premix Indications

1. As an aid in the prevention of coccidiosis caused by E. necatrix, E. tenella, E. acervulina, E. brunetti, E. mitis, and E. maxima in broiler chickens.

2. As an aid in the prevention of coccidiosis in growing turkeys caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis.

IMPORTANT: Must be thoroughly mixed in feeds before use.

ACTIVE DRUG INGREDIENT:

Monensin (as monensin sodium)

200.0 g per kilogram

MIXING DIRECTIONS:

(Claims 1 and 2)

Thoroughly mix 495 g (0.495 kg) of Rumensin Premix in 1 tonne (1,000 kg) of feed to provide monensin at 99 g monensin activity per tonne of feed. It is recommended that Rumensin Premix be mixed with a small quantity of the finishing feed before it is incorporated into the bulk of the feed being prepared.

FEEDING DIRECTIONS:

Feed continuously as the sole ration to broiler chickens.

Feed continuously as the sole ration to growing turkeys.

Warnings

1. Do not feed to replacement and laying chickens and turkeys.

2. When mixing and handling Rumensin Premix, use protective clothing, impervious gloves, and a dust mask. Operators should wash thoroughly with soap and water after handling.

3. No pre-slaughter withdrawal period is required when this drug is used according to the label.

4. Keep out of reach of children.

CAUTIONS:

1. May be used in feeds containing the pellet-binding agents, Bentonite (2%), Attapulgite (2%), Kaolin (2.5%), Lignin Sulfonate (4%), Carboxymethylcellulose (0.1%) or Agri-Colloid.

2. Do not allow canines, horses, other equines, or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.

3. Poultry consuming monensin should not be treated with products containing tiamulin. Severe growth depression may occur.

4. Do not use this mixture for treatment of outbreaks of coccidiosis.

5. Some species of turkey coccidia may be monensin tolerant.

6. NOT TO BE USED AFTER EXPIRATION DATE.

STORE IN A COOL DRY PLACE.

Elanco, Rumensin and the diagonal bar are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

Microtracer is a trademark of Micro Tracers Inc., U.S.A., used under license.

ELANCO, Division Eli Lilly Canada, Inc., 150 Research Lane, Suite 120, Guelph, Ontario N1G 4T2

Net Weight

 

25 kg bag

Revised 5-May-14

500 kg tote

Revised 5-May-14

NAC No.: 1184010.7

ELANCO
Division Eli Lilly Canada Inc.

RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
Telephone:   519-821-0277
Order Desk:   800-773-7603
Fax:   519-821-7831
Website:   www.Elanco.ca
Every effort has been made to ensure the accuracy of the Rumensin Premix information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web1)